Loading…
Healthcare Triangle, Inc. is projected to rise to $1.11 by 2027, a +9% move from its current price of $1.02. HCTI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.9535 | $1.02 | $1.09 | +0.16% |
| Aug 6 | $0.9281 | $1.02 | $1.13 | +0.31% |
| Aug 7 | $0.9094 | $1.02 | $1.15 | +0.47% |
| Aug 8 | $0.8941 | $1.03 | $1.18 | +0.63% |
| Aug 9 | $0.881 | $1.03 | $1.20 | +0.79% |
| Aug 10 | $0.8695 | $1.03 | $1.22 | +0.94% |
| Aug 11 | $0.8592 | $1.03 | $1.24 | +1.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.8592 | $1.03 | $1.24 | +1.10% |
| Week 2 | $0.8054 | $1.04 | $1.35 | +2.21% |
| Week 3 | $0.7683 | $1.05 | $1.45 | +3.34% |
| Week 4 | $0.7397 | $1.07 | $1.54 | +4.48% |
| Week 5 | $0.7163 | $1.08 | $1.62 | +5.63% |
| Week 6 | $0.6965 | $1.09 | $1.70 | +6.79% |
| Week 7 | $0.6794 | $1.10 | $1.78 | +7.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Healthcare Triangle, Inc. is a healthcare information technology company focusing on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.
Its software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain infrastructure; and Cybersecurity navigator. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports.
Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California.
Healthcare Triangle, Inc. (HCTI) trades at $1.15 per share, with a market capitalization of $2.32M and a global rank of 5136. These figures place the stock among a broad set of small-cap healthcare IT names.
The current price context is informed by a forecast that spans 2026 through 2050, with varying minimum, average, and maximum prices and corresponding ROI figures. The near-term outlook shows a flat to modestly rising path through 2027, while longer-term forecasts indicate stronger upside potential beginning around 2032 and peaking by 2050.
A major floor 63.4% below — a decisive break under it would weaken the trend.
Support has flipped 7.8% overhead — reclaiming it would be bullish.
The nearest ceiling, 114.7% above — a clean break opens room to run.
A major ceiling 186.3% above — clearing it would confirm fresh momentum.
Key HCTI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HCTI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.43 | Sell | $1.35 | Sell |
| MA 10 | $1.58 | Sell | $1.51 | Sell |
| MA 20 | $1.70 | Sell | $1.67 | Sell |
| MA 50 | $2.03 | Sell | $2.44 | Sell |
| MA 100 | $2.26 | Sell | $25.83 | Sell |
| MA 200 | $41.44 | Sell | $540.27 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 23.57 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -276.16 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -41.80 | Sell |
| Bollinger %B (20,2) | -0.20 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.98 | Sell |
| Awesome (5,34) | -0.42 | Sell |
| Ultimate (7,14,28) | 15.93 | Buy |
| Momentum (10) | -0.74 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 1.22 | Sell |
| ADX (14) | 25.89 | Sell |
| ATR (14) | 0.09 | Info |
The 30-day technical picture is neutral in tone, with RSI14 at 20. Price momentum remains limited and could reflect subdued buying pressure.
Price action is trading below the near-term average benchmarks, with SMA50 at $2.05 and SMA200 at $42.29, indicating the current price sits well under both moving averages.
Key levels from the data show support at $1.14 and resistance at $2.22, with a 30-day trading range from $0.7169 to $1.83. These levels can help frame near-term risk and potential entry points if price activity consolidates near the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.02 | $1.02 | $1.56 | 0% | Neutral | |
| $0.8093 | $1.11 | $1.65 | +9% | Neutral | |
| $0.7325 | $1.07 | $1.69 | +5% | Neutral | |
| $0.6105 | $0.9391 | $1.56 | -8% | Neutral | |
| $0.5784 | $0.9329 | $1.62 | -9% | Neutral | |
| $0.6255 | $1.05 | $1.89 | +3% | Neutral | |
| $0.7451 | $1.31 | $2.42 | +28% | Bullish | |
| $0.8413 | $1.54 | $2.93 | +51% | Bullish | |
| $0.6698 | $1.28 | $2.49 | +25% | Bullish | |
| $0.5465 | $1.08 | $2.16 | +6% | Neutral | |
| $0.7136 | $1.59 | $3.48 | +55% | Bullish | |
| $1.49 | $3.32 | $7.63 | +225% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.02 | $1.02 | $1.30 | +0.00% |
| September 2026 | $0.9512 | $1.16 | $1.47 | +13.36% |
| October 2026 | $0.9544 | $1.18 | $1.52 | +1.74% |
| November 2026 | $0.9102 | $1.13 | $1.49 | -3.54% |
| December 2026 | $0.9303 | $1.17 | $1.56 | +3.29% |
Click any year to see its month-by-month HCTI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, HCTI is projected to trade between $1.02 and $1.56, averaging $1.02 — a potential gain of 0% from today's $1.02. A consolidation phase looks the most probable path here.
Healthcare Triangle, Inc.'s 2027 outlook centres on $1.11, within a $0.8093 to $1.65 range. That is up +9% on the projected 2026 average. That marks a +9% change versus current levels. Price action looks broadly range-bound.
By 2028, HCTI could reach as high as $1.69, with a base case around $1.07 and support toward $0.7325 — roughly +5% from $1.02. A consolidation phase looks the most probable path here.
Expect HCTI to range from $0.6105 to $1.56 through 2029. The $0.9391 average target implies a -8% move from current prices. That is -12% versus the projected 2028 average. Price action looks broadly range-bound.
The HCTI price prediction for 2030 points to an average of $0.9329 (low $0.5784, high $1.62) — a potential decline of -9% on today's $1.02. A consolidation phase looks the most probable path here.
In 2031, HCTI is projected to trade between $0.6255 and $1.89, averaging $1.05 — a potential gain of +3% from today's $1.02. That is up +13% on the projected 2030 average. Price action looks broadly range-bound.
Healthcare Triangle, Inc.'s 2032 outlook centres on $1.31, within a $0.7451 to $2.42 range. That is up +24% on the projected 2031 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, HCTI could reach as high as $2.93, with a base case around $1.54 and support toward $0.8413 — roughly +51% from $1.02. Momentum favours further upside here.
Expect HCTI to range from $0.6698 to $2.49 through 2034. The $1.28 average target implies a +25% move from current prices. That is -17% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The HCTI price prediction for 2035 points to an average of $1.08 (low $0.5465, high $2.16) — a potential gain of +6% on today's $1.02. Price action looks broadly range-bound.
In 2040, HCTI is projected to trade between $0.7136 and $3.48, averaging $1.59 — a potential gain of +55% from today's $1.02. That is up +46% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Healthcare Triangle, Inc.'s 2050 outlook centres on $3.32, within a $1.49 to $7.63 range. That is up +109% on the projected 2040 average. That marks a +225% change versus current levels. Momentum favours further upside here.
Investing $1,000 in HCTI today (≈ 980.392157 HCTI) could be worth
$3,251.42
+$2,251.42 (+225%) by 2050 · US Dollar
Based on the average projected HCTI price of $3.32 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HCTIwould be worth at today's price.
$1,000 invested in HCTI on Jul 31, 2025 (≈ 2.159174 HCTI) would be worth
$2.2
-$997.8 (-99.8%) today · 0.00× · US Dollar
Based on a HCTI entry price of $463.14 vs. today's $1.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.62 | $629.63 | -37.0% |
| 1 month ago | $1.94 | $525.77 | -47.4% |
| 3 months ago | $2.3 | $443.48 | -55.7% |
| 6 months ago | $15.42 | $66.15 | -93.4% |
| 1 year ago | $463.14 | $2.2 | -99.8% |
| All time (4.8y) ago | $536,346 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HCTI forecast.
Our base-case forecast reaches $2.00 around 2050.
Implied market cap at $2.00: $4.06M
The multi-year forecast shows a mixed start to the horizon with near-term volatility: 2026 min $1.14, avg $1.15, max $1.77 and ROI 0%; 2027 min $0.9017, avg $1.24, max $1.84 with ROI 8.2%; 2028 min $0.8196, avg $1.20, max $1.90 with ROI 4.5%; 2029 min $0.6934, avg $1.07, max $1.77 with ROI -6.8%; 2030 min $0.6415, avg $1.04, max $1.79 with ROI -9.6%.
From 2032 onward, forecasts turn more constructive: 2032 min $0.8466, avg $1.49, max $2.76 with ROI 30.1%; 2033 min $0.938, avg $1.72, max $3.27 with ROI 50.1%; 2034 min $0.7472, avg $1.42, max $2.78 with ROI 24.4%; 2035 min $0.6186, avg $1.23, max $2.45 with ROI 7.1%.
In the longer run, the outlook strengthens further: 2040 min $0.8009, avg $1.78, max $3.90 with ROI 55.4%; and 2050 min $1.69, avg $3.76, max $8.64 with ROI 228.1%. Sentiment is listed as BULLISH for 2032 and beyond, reflecting a stronger potential upside, though early years carry downside risk. These figures are estimates and not guarantees.
Tap a question to reveal the answer.
2030 forecast: min $0.6415, avg $1.04, max $1.79; ROI -9.6%; sentiment NEUTRAL.
Near term outlook is NEUTRAL with 2026 avg $1.15 and ROI 0%, and 2027 avg $1.24 with ROI 8.2%. Early years 2029–2030 show negative ROI, while longer-term forecasts turn more bullish starting 2032.
Yes, the forecasted max price by 2050 is $8.64, with 2050 avg $3.76 and ROI 228.1%.
RSI14 is 20 with sentiment NEUTRAL. SMA50 is $2.05 and SMA200 is $42.29. Support is at $1.14 and resistance at $2.22. The 30-day range is $0.7169 to $1.83.
For 2050, min $1.69, avg $3.76, max $8.64 with ROI 228.1% and sentiment BULLISH.
Healthcare Triangle, Inc. Community Discussion
0Share your Healthcare Triangle, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.